210 related articles for article (PubMed ID: 22564515)
1. Review of the molecular profile and modern prognostic markers for gastric lymphoma: how do they affect clinical practice?
Alevizos L; Gomatos IP; Smparounis S; Konstadoulakis MM; Zografos G
Can J Surg; 2012 Apr; 55(2):117-24. PubMed ID: 22564515
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients.
Darom A; Gomatos IP; Leandros E; Chatzigianni E; Panousopoulos D; Konstadoulakis MM; Androulakis G
World J Gastroenterol; 2006 Mar; 12(12):1924-32. PubMed ID: 16610000
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas.
Dogusoy G; Karayel FA; Göcener S; Göksel S
Pathol Oncol Res; 1999; 5(1):36-40. PubMed ID: 10079376
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases.
Wang YG; Zhao LY; Liu CQ; Pan SC; Chen XL; Liu K; Zhang WH; Yang K; Chen XZ; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Medicine (Baltimore); 2016 Aug; 95(31):e4250. PubMed ID: 27495029
[TBL] [Abstract][Full Text] [Related]
5. The use of molecular biology in diagnosis and prognosis of gastric cancer.
Becker KF; Keller G; Hoefler H
Surg Oncol; 2000 Jul; 9(1):5-11. PubMed ID: 11525306
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome.
Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C
Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208
[TBL] [Abstract][Full Text] [Related]
7. Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.
Shan Z; Wang W; Tong Y; Zhang J
Med Sci Monit; 2021 Mar; 27():e929558. PubMed ID: 33758160
[TBL] [Abstract][Full Text] [Related]
8. [Primary stomach lymphoma. An assessment of the current status].
Fischbach W; Böhm S
Z Gastroenterol; 1994 Jun; 32(6):354-9. PubMed ID: 7975766
[TBL] [Abstract][Full Text] [Related]
9. [Survival in patients with gastric lymphoma].
Ouakaa-Kchaou A; Gargouri D; Elloumi H; Kochlef A; Bouzid H; Kilani A; Romani M; Kharrat J; Ghorbel A
Tunis Med; 2011 Oct; 89(10):752-7. PubMed ID: 22076896
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.
Bamias AT; Bai MC; Agnantis NJ; Michael MC; Alamanos YP; Stefanaki SV; Razi ED; Skarlos DV; Kappas AM; Pavlidis NA
Cancer Invest; 2003 Jun; 21(3):333-40. PubMed ID: 12901278
[TBL] [Abstract][Full Text] [Related]
11. Primary gastric lymphoma: a review of 45 cases.
Ravaioli A; Amadori M; Faedi M; Rosti G; Folli S; Barbieri C; Giorgini G; Marangolo M; Emiliani E; Amadori D
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1461-5. PubMed ID: 3595671
[TBL] [Abstract][Full Text] [Related]
12. Fluctuating expression of miR-584 in primary and high-grade gastric cancer.
Ebrahimi Ghahnavieh L; Tabatabaeian H; Ebrahimi Ghahnavieh Z; Honardoost MA; Azadeh M; Moazeni Bistgani M; Ghaedi K
BMC Cancer; 2020 Jul; 20(1):621. PubMed ID: 32615958
[TBL] [Abstract][Full Text] [Related]
13. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
14. [Current therapy concepts of stomach lymphoma].
Fischbach W
Z Gastroenterol; 2002 Dec; 40 Suppl 2():24-6. PubMed ID: 12467000
[No Abstract] [Full Text] [Related]
15. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
[TBL] [Abstract][Full Text] [Related]
16. Protein expression of bax, bcl-2, and p53 in patients with non-Hodgkin's gastric lymphoma: prognostic significance.
Charalambous GK; Gomatos IP; Konstadoulakis MM; Messaris EG; Manouras AJ; Apostolou AE; Leandros EA; Karayannis MK; Androulakis GA
World J Surg; 2000 May; 24(5):608-14. PubMed ID: 10787085
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics and therapeutic outcomes of synchronous gastric adenocarcinoma and gastric lymphoma.
Namikawa T; Munekage E; Fukudome I; Maeda H; Kitagawa H; Togitani K; Takasaki M; Yokoyama A; Kobayashi M; Hanazaki K
Anticancer Res; 2014 Sep; 34(9):5067-74. PubMed ID: 25202092
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic and molecular features associated with patient age in gastric cancer.
Seo JY; Jin EH; Jo HJ; Yoon H; Shin CM; Park YS; Kim N; Jung HC; Lee DH
World J Gastroenterol; 2015 Jun; 21(22):6905-13. PubMed ID: 26078567
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
[TBL] [Abstract][Full Text] [Related]
20. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
Tang H; Deng M; Tang Y; Xie X; Guo J; Kong Y; Ye F; Su Q; Xie X
Clin Cancer Res; 2013 Oct; 19(20):5602-12. PubMed ID: 23995857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
